Lung cancer screening, overdiagnosis bias, and reevaluation of the mayo lung project

Journal of the National Cancer Institute

Volumn 98, Issue 11, 2006, Pages 724-725

  Patz Jr , Edward F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDITORIAL; HEALTH SURVEY; HUMAN; LUNG CANCER; PRIORITY JOURNAL; SPUTUM ANALYSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MORTALITY; NOTE; OBSERVER VARIATION; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UNITED STATES;

BOSTON; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; MASS SCREENING; OBSERVER VARIATION; PHILADELPHIA; RANDOMIZED CONTROLLED TRIALS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 33745257269     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj226     Document Type: Editorial

References (21)

1. Scamman CL. Follow-up study of lungcancer suspects in a mass chest x-ray survey. N Engl J Med 1951;244:541-4.
2. Boucot KR, Carnahan W, Cooper DA, Nealon T Jr, Ottenberg DJ, Theodos PA. Philadelphia pulmonary neoplasm research project; preliminary report. J Am Med Assoc 1955;157:440-4.
3. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984;130:561-5.
4. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer 1991;67(4 Suppl):1155-64.
5. Fontana t, Sanderson DR, Woolner LB, Miller WE, Bernatz PE, Payne WS, et al. The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: A status report. Chest 1975;67:511-22.
6. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98:748-56.
7. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al. Early lung cancer action project: Initial findings on repeat screenings. Cancer 2001;92:153-9.
8. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: Five-year prospective experience. Radiology 2005;235:259-65.
9. Pastorino U, Bellomi M, Landoni C, De Fiori E, Arnaldi P, Picchio M, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-7.
10. McFarlane MJ, Feinstein AR, Wells CK. Necropsy evidence of detection bias in the diagnosis of lung cancer. Arch Intern Med 1986;146:1695-8.
11. McFarlane MJ, Feinstein AR, Wells CK. Clinical features of lung cancers discovered as a postmortem "surprise". Chest 1986;90:520-3.
12. McFarlane MJ, Feinstein AR, Wells CK, Chan CK. The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. JAMA 1987;258:331-8.
13. Chan CK, Wells CK, McFarlane MJ, Feinstein AR. More lung cancer but better survival. Implications of secular trends in "necropsy surprise" rates. Chest 1989;96:291-6.
14. Dammas S, Patz EF Jr, Goodman PC. Identification of small lung nodules at autopsy: Implications for lung cancer screening and overdiagnosis bias. Lung Cancer 2001;33:11-6.
15. Henschke CI, Shaham D, Yankelevitz DF, Kramer A, Kostis WJ, Reeves AP, et al. CT screening for lung cancer: Significance of diagnoses in its baseline cycle. Clin Imaging 2006;30:11-5.
16. Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H, et al. Peripheral lung adenocarcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220:803-9.
17. Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. "Early" peripheral lung cancer: Prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74:1635-9.
18. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: A favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003;76:1016-22.
19. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M, et al. Prognostic value of ground-glass opacity found in small lung adeno-carcinoma on high-resolution CT scanning. Lung Cancer 2001;33:17-25.
20. Hillman BJ. Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer. Acad Radiol 2003;10:349-50.
21. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: The Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-21.